HOXA9 has been shown to be dysregulated in many solid tumors, including lung cancer [20], and in vitro experiments have found downregulation of HOXA9 to enhance migratory potential [21] and stimulate cell invasiveness [22]. Here, HOXA9 is linked to lung carcinoma.